未登录 Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer Jiang, Di Maria; Parshad, Shruti; Zhan, Luna; Sim, Hao-Wen; Siu, Lillian L.; Liu, Geoffrey; Shapiro, Jeremy D.; Price, Timothy J.; Jonker, Derek J.; Karapetis, Christos S.; Strickland, Andrew H.; Zhang, Wenjiang; Jeffery, Mark; Tu, Dongsheng; Ng, Siobhan; Sabesan, Sabe; Shannon, Jenny; Townsend, Amanda; O'Callaghan, Chris J.; Chen, Eric X. 分享 收藏
Circulating-tumour DNA (ctDNA) detection using an ultra-sensitive next generation sequencing (NGS)-based assay in patients with resected colorectal cancer (CRC) in the phase III ASCOLT trial Day, D.; Starus, A.; Sieber, O.; Prasse, D.; Lamik, A.; Fredebohm, J.; Simes, J.; Day, F.; Jeffery, M.; Zielinski, R.; Singh, M.; Chong, G.; Li, S.; Mouradov, D.; Chia, J.; Ali, R.; Toh, H.; Jones, F.; Segelov, E. 分享 收藏
分享 收藏
分享 收藏
Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer Hill, Andrew G.; Findlay, Michael P.; Burge, Matthew E.; Jackson, Christopher; Alfonso, Pilar Garcia; Samuel, Leslie; Ganju, Vinod; Karthaus, Meinolf; Amatu, Alessio; Jeffery, Mark; Di Bartolomeo, Maria; Bridgewater, John; Coveler, Andrew L.; Hidalgo, Manuel; Kapp, Amy V.; Sufan, Roxana I.; McCall, Bruce B.; Hanley, William D.; Penuel, Elicia M.; Pirzkall, Andrea; Tabernero, Josep 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Randomized phase II study of duligotuzumab plus FOLFIRI versus cetuximab plus FOLFIRI in 2nd-line patients with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) Hill, Andrew G.; Findlay, Michael; Burge, Matthew; Jackson, Christopher; Garcia Alfonso, Pilar; Samuel, Leslie; Ganju, Vinod; Karthaus, Meinolf; Amatu, Alessio; Jeffery, Mark; DiBartolomeo, Maria; Bridgewater, John; Coveler, Andrew; Hidalgo, Manuel; Kapp, Amy V.; Sufan, Roxana; McCall, Bruce; Penuel, Elicia; Pirzkall, Andrea; Tabernero, Josep 分享 收藏
分享 收藏
分享 收藏
A Phase Ib study of demcizumab (DEM, anti-DLL4) with gemcitabine (GEM) in patients with first line locally advanced or metastatic pancreatic cancer. Cubillo, Antonio; Jameson, Michael; Grande, Enrique; Parnis, Francis; Grimison, Peter; Cooray, Prasad; Jeffery, Mark; Stagg, Robert; Dupont, Jakob; Tebbutt, Niall 分享 收藏
Quality of Life in Patients With K-RAS Wild-Type Colorectal Cancer Ringash, Jolie; Au, Heather-Jane; Siu, Lillian L.; Shapiro, Jeremy D.; Jonker, Derek J.; Zalcberg, John R.; Moore, Malcolm J.; Strickland, Andrew; Kotb, Rami; Jeffery, Mark; Alcindor, Thierry; Ng, Siobhan; Salim, Muhammad; Sabesan, Sabe; Easaw, Jay C.; Shannon, Jenny; El-Tahche, Fabyolla; Walters, Ian; Tu, Dongsheng; O'Callaghan, Christopher J. 分享 收藏
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)-results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care Asmis, T. R.; Powell, E.; Karapetis, C. S.; Jonker, D. J.; Tu, D.; Jeffery, M.; Pavlakis, N.; Gibbs, P.; Zhu, L.; Dueck, D. -A.; Whittom, R.; Langer, C.; O'Callaghan, C. J. 分享 收藏
分享 收藏
Transient Retinal Effects of 5,6-Dimethylxanthenone-4-acetic Acid (DMXAA, ASA404), an Antitumor Vascular-Disrupting Agent in Phase I Clinical Trials Jameson, Michael B.; Sharp, Dianne M.; Sissingh, Jennifer I.; Hogg, Christopher R.; Thompson, Paul I.; McKeage, Mark J.; Jeffery, Mark; Waller, Susan; Acton, Gary; Green, Colin; Baguley, Bruce C. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}